Results 81 to 90 of about 28,278 (262)
Using Interleukin 6 and 8 in Blood and Bronchoalveolar Lavage Fluid to Predict Survival in Hematological Malignancy Patients With Suspected Pulmonary Mold Infection. [PDF]
Background: Molds and other pathogens induce elevated levels of several cytokines, including interleukin (IL)-6 and IL-8. The objective of this study was to investigate the prognostic value of IL-6 and IL-8 as well as fungal biomarkers in blood and ...
Eigl, Susanne +12 more
core +1 more source
Infrared Spectroscopy as a Promising Tool for Diagnosing and Typing Human Pathogenic Fungi
ABSTRACT Fungal infections are increasingly recognised as a global health challenge, responsible for millions of cases annually and substantial mortality, especially in immunocompromised individuals. Yet, the diagnosis of these infections remains notoriously difficult, often delayed by slow culture‐based methods or hindered by the high cost and ...
Anthony G. J. Medeiros +8 more
wiley +1 more source
Multicenter evaluation of a lateral-flow device test for diagnosing invasive pulmonary aspergillosis in ICU patients. [PDF]
Published onlineClinical TrialJournal ArticleMulticenter StudyResearch Support, Non-U.S. Gov'tINTRODUCTION: The incidence of invasive pulmonary aspergillosis (IPA) in intensive care unit (ICU) patients is increasing, and early diagnosis of the disease ...
Buchheidt, D +18 more
core +1 more source
Asthma in Patients With Confirmed Pulmonary Sarcoidosis
Pulmonary sarcoidosis and asthma can present identical symptoms, making clinical evaluation difficult if the two diseases overlap. Diagnostic challenges often lead to either overdiagnosis of asthma in patients with confirmed sarcoidosis or withholding appropriate asthma treatment.
Agata Anna Lewandowska +9 more
wiley +1 more source
Bronchoscopic view showing an obstructive tumor‐like lesion arising from the right main bronchus, consistent with tracheobronchial aspergillosis. ABSTRACT Tracheobronchial aspergillosis (TBA) is an uncommon form of invasive Aspergillus infection that can closely mimic endobronchial malignancy, particularly when presenting as an obstructive ...
Cinthya Castillo Gamboa +3 more
wiley +1 more source
ABSTRACT Liposomal amphotericin B (L‐AmB), as a modified formulation of traditional amphotericin B, have better targeting and lower toxicity. However, clinicians have limited experience with the use of L‐AmB for the treatment of Aspergillus flavus (A. flavus) at present.
Xianqiu Chen +7 more
wiley +1 more source
Introduction Invasive and semi-invasive pulmonary aspergillosis usually occurs in immunocompromised patients. It has been described occasionally in patients with normal immunity and previous lung disease such as chronic obstructive pulmonary disease ...
Semedo Júlio ANMQ +5 more
doaj +1 more source
Genetic susceptibility to aspergillosis in allogeneic stem-cell transplantation [PDF]
Invasive aspergillosis (IA) is a major threat to positive outcomes for allogeneic stem-cell transplantation (allo-SCT) patients. Despite presenting similar degrees of immunosuppression, not all individuals at-risk ultimately develop infection. Therefore,
Agostinho Carvalho +48 more
core +1 more source
Treatment for chronic to invasive pulmonary aspergillosis typically involves azole antifungal drugs, although studies have shown varying minimum inhibitory concentrations (MIC) for these medications, with a growing concern over voriconazole resistance.
Aishwarya Nikhil +8 more
wiley +1 more source
Invasive pulmonary aspergillosis (IPA) is a disease of immunocompromised patients, but its prevalence is increasing in immunocompetent persons. Patients usually present with non-specific symptoms, sometimes consistent with bronchopneumonia.
Moti lal Bunkar +2 more
doaj +1 more source

